GlassScriptPhysician profile
Shannon Comley Sood
NPI 1902811615
$8,677.04
in general payments reported to CMS, 2019-2025
45 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $378 · 2021: $1,121 · 2022: $1,468 · 2023: $2,010 · 2024: $1,738 · 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,999 · Education: $16.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,999.09 |
| Education | $16.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $839.22 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $791.25 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $734.17 | 2019-2025 | Evenity, Tepezza, Prolia |
| Dexcom, INC. | $662.60 | 2019-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $536.85 | 2020-2025 | Freestyle Libre 3 |
| Insulet Corporation | $450.35 | 2019-2024 | Omnipod |
| Medtronic, INC. | $432.18 | 2021-2025 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $414.47 | 2019-2024 | |
| Antares Pharma, INC. | $354.82 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Recordati_rare_diseases_inc. | $349.33 | 2022-2025 | Isturisa, Signifor Lar |
| Corcept Therapeutics | $322.95 | 2019-2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $286.14 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Mannkind Corporation | $229.86 | 2019-2025 | Afrezza |
| Sequel Med Tech, LLC | $202.80 | 2025 | Twiist |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.04 | 2020-2025 | Jardiance |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $197.54 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $141.34 | 2021-2024 | Synthroid |
| Ibsa Pharma INC. | $128.96 | 2020-2024 | Tirosint, Licart, Tirosint |
| Amneal Pharmaceuticals LLC | $127.28 | 2021-2023 | Unithroid |
| Astrazeneca Pharmaceuticals LP | $124.87 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $110.08 | 2023-2025 | Strensiq |
| Beta Bionics, INC. | $101.34 | 2024 | Ilet Bionic Pancreas |
| Bayer Healthcare Pharmaceuticals INC. | $97.54 | 2021-2024 | |
| Ascensia Diabetes Care US INC. | $84.88 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $75.28 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $71.82 | 2019-2023 | Steglatro, Steglujan |
| Ascendis Pharma Endocrinology INC | $69.42 | 2024-2025 | Yorvipath |
| Halozyme INC | $67.42 | 2023 | |
| Renalytix Ai, INC. | $62.22 | 2022-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Embecta Corp. | $60.73 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Radius Health, INC. | $54.29 | 2019-2023 | |
| Intuity Medical INC | $38.97 | 2022 | |
| Horizon Therapeutics Plc | $35.16 | 2021 | |
| Pfizer INC. | $26.65 | 2019-2020 | |
| Rhythm Pharmaceuticals, INC. | $24.95 | 2022 | |
| Shire North American Group INC | $24.20 | 2019 | |
| Eusa Pharma (US) LLC | $21.41 | 2022 | |
| Becton, Dickinson and Company | $17.98 | 2022 | |
| Rgh Enterprises LLC | $17.57 | 2024 | |
| Lifescan, INC. | $16.19 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $16.19 | 2022 | |
| Eisai INC. | $15.94 | 2019 | |
| Cequr Corporation | $15.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.47 | 2019 | |
| Currax Pharmaceuticals LLC | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Comley Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.